Tags: Drug.
Bivatuzumab mertansine is a combination of bivatuzumab a humanized monoclonal antibody and mertansine a cytotoxic agent. It is designed for the treatment of squamous cell carcinoma.
Loading...
This page contains content from the copyrighted Wikipedia article "Bivatuzumab mertansine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.